| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |